Retrophin Reports Fourth Quarter and Full Year 2017 Financial Results
Feb 27, 2018 21:01 pm UTC| Business
Company gains alignment to proceed on Subpart H accelerated approval pathway for sparsentan in FSGS; Study start-up activities ongoing to initiate Phase 3 pivotal trial in second quarter of 2018 Clinical development of...
Feb 27, 2018 21:01 pm UTC| Business
LIVONIA, Mich., Feb. 27, 2018 -- Gemphire Therapeutics Inc. (NASDAQ:GEMP), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for cardiometabolic disorders, including...
Feb 27, 2018 21:01 pm UTC| Business
CRANBURY, N.J., Feb. 27, 2018 -- Amicus Therapeutics (Nasdaq:FOLD) is honoring Rare Disease Day this week with the launch of Healing Beyond Disease™, a global, Amicus employee-driven initiative inspired by people living...
Big 5 Sporting Goods Corporation Announces Fiscal 2017 Fourth Quarter and Full-Year Results
Feb 27, 2018 21:01 pm UTC| Business
EL SEGUNDO, Calif., Feb. 27, 2018 -- Big 5 Sporting Goods Corporation (NASDAQ:BGFV) (the “Company”), a leading sporting goods retailer, today reported financial results for the fiscal 2017 fourth quarter and full year...
Feb 27, 2018 21:01 pm UTC| Business
CAMBRIDGE, Mass., Feb. 27, 2018 -- Editas Medicine, Inc. (NASDAQ:EDIT), a leading genome editing company, today announced that it will host a conference call and webcast on Tuesday, March 6th, 2018, at 5:00 p.m. ET to...
Red Rock Resorts Announces Fourth Quarter and Year End 2017 Results
Feb 27, 2018 21:01 pm UTC| Business
LAS VEGAS, Feb. 27, 2018 -- Red Rock Resorts, Inc. ("Red Rock Resorts," "we" or the "Company") (NASDAQ:RRR) today reported financial results for the fourth quarter and year ended December 31, 2017. Net revenues were...
MacroGenics Provides Update on Corporate Progress and 2017 Financial Results
Feb 27, 2018 21:01 pm UTC| Business
ROCKVILLE, Md., Feb. 27, 2018 -- MacroGenics, Inc. (NASDAQ:MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of...